Dr. Annie De Groot will be in Japan from October 7th – 11th, to meet with collaborators and to host a semi-annual seminar on immunogenicity.

The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, tolerance induction).

Full Agenda Here – 議題

Please check this page for updates.

To Confirm Your Attendence: Email Us Here

Westin Immunogenicity Seminar Seminar Osaka 2013

Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island (URI) & EpiVax, Inc.

Venue: The Westin Osaka

Tuesday, October 8th, 9:00 am – 5:00 pm

4th Floor Sara Room and Lunch is 4th Floor Kikyo Room
Lunch is provided
1-1-2 0 Oyodonaka, Kita Ward, Osaka, Osaka Prefecture 531-0076, Japan

Dr. Keizo Yoshida, PhD.
EpiVax Asia

Prof. Annie De Groot, M.D.
Professor and Director, Institute of Immunology and Informatics,
University of Rhode Island, CEO/CSO, EpiVax

Prof. Shimon Sakaguchi, M.D., Ph.D
Principal Investigator
Immunology (Immunological tolerance and autoimmune disease)
Osaka University

Prof. David W. Scott, PhD
Professor of Medicine
Vice Chair for Research
Department of Medicine (MED)
Uniformed Services University of Health Sciences

Prof. Ken Ishii, M.D., Ph.D
Project Leader
National Institute of Biomedical Innovation
Professor, PI
Laboratory of Vaccine Science, Osaka University

Please check this site for up-to-date information on the Westin Immunogenicity Seminar Osaka 2013.

Full Agenda Here – 議題

To Confirm Your Attendence: Email Us Here